Study guide
Endophthalmitis diagnosis and treatment
European Board of Ophthalmology Diploma EBOD
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: EBOD Examination, Applications and Regulations
EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals
2 Chapter 2: Physical Optics, Photometry and Lenses
Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid
3 Chapter 3: Instrument Optics, Aberrations and Laser Physics
Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT
4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing
Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses
5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation
Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics
6 Chapter 6: Extraocular Anatomy and Motor Physiology
Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys
7 Chapter 7: Binocular Vision and Amblyopia
Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment
8 Chapter 8: Childhood Assessment and Strabismus Testing
Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts
9 Chapter 9: Esotropia, Exotropia and Vertical Deviations
Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew
10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery
Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles
11 Chapter 11: ROP and Paediatric Ocular Disease
Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding
12 Chapter 12: Ocular Surface Anatomy and Infection
Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis
13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation
Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis
14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies
Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies
15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure
Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency
16 Chapter 16: Surface Reconstruction and Keratoplasty
Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems
17 Chapter 17: Lens Development, Cataract Assessment and Biometry
Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry
18 Chapter 18: IOL Planning and Phacoemulsification
Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques
19 Chapter 19: Cataract Anaesthesia and Surgical Complications
Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO
20 Chapter 20: Corneal and Intraocular Refractive Surgery
Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange
21 Chapter 21: Presbyopia Procedures and Surface Therapeutics
Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin
22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy
Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation
23 Chapter 23: Angle, Disc and Visual-Field Assessment
Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry
24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms
Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure
25 Chapter 25: POAG, Angle Closure and Pigmentary Disease
POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma
26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment
Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers
27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion
Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions
28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy
Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis
29 Chapter 29: Inherited Retina and Electrophysiology
Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina
30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid
AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum
31 Chapter 31: Retinal Breaks and Detachment Repair
PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling
32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma
Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment
33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation
SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation
34 Chapter 34: Infectious Uveitis and Endophthalmitis
Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment
35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy
Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison
36 Chapter 36: Papilloedema, IIH and Afferent Localisation
Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization
37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology
Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies
38 Chapter 38: Central Motor Control and Cranial Nerve Palsies
Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus
39 Chapter 39: Myasthenia and Ocular Myopathy
Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome
40 Chapter 40: Pupillary Pathways and Anisocoria
Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials
41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment
Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation
42 Chapter 42: Lid Repair and Lacrimal Drainage
Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR
43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours
Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma
44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease
Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling
45 Chapter 45: Ocular Trauma and Vascular Systemic Disease
Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease
46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology
Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects
47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations
Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal
Endophthalmitis diagnosis and treatment
Key Takeaways Explain This Topic AI
Suspected endophthalmitis is an urgent clinical diagnosis requiring appropriate sampling and intravitreal treatment.
EVS evidence concerns a defined postoperative population and cannot be applied unchanged to every infection source.
Endogenous, traumatic and bleb-related disease require their own organism, systemic and surgical considerations.
Last updated: October 2026
Acute Post-Cataract Endophthalmitis
Acute post-cataract endophthalmitis represents a catastrophic purulent intraocular infection involving the vitreous and anterior chambers. The reported incidence across modern European phacoemulsification cohorts ranges between 0.03% and 0.08% (approximately 1 in 1,200 to 1 in 3,000 surgeries). Routine intracameral cefuroxime (1.0 mg in 0.1 mL) prophylaxis at the conclusion of surgery has decreased the incidence five-fold (as demonstrated in the landmark ESCRS multicenter study).
Clinical Presentation and Timing
Timeline: Characteristically presents between postoperative days 3 and 7 (median onset: day 5). Presentations after 6 weeks are classified as chronic pseudophakic endophthalmitis (typically caused by low-virulence organisms such as Cutibacterium acnes , Corynebacterium , or fungi).
Primary Source: In > 80 % >80\% > 80% of cases, molecular typing confirms that the infecting organism originates from the patient's own ocular surface flora (eyelashes, eyelid margin, and conjunctival sac) entering the eye during surgery or through an unsealed clear corneal wound in the early postoperative period.
Symptoms:
Rapid, progressive deterioration of visual acuity out of proportion to normal postoperative recovery;
Severe, deep, throbbing ocular and periorbital pain ( important exam caveat: pain is absent in up to 25% of patients , meaning absence of pain never excludes endophthalmitis);
Marked photophobia, eyelid oedema, and red eye.
Physical Signs:
- Eyelid oedema and profound conjunctival/ciliary injection;
- Corneal epithelial and stromal oedema with Descemet folds;
- Dense anterior chamber cells, fibrin membranes across the pupil/IOL, and a progressive hypopyon ;
Dense vitritis obscuring retinal vessel architecture and complete loss of the red reflex on distant direct ophthalmoscopy.
Microbiology of Acute Postoperative Endophthalmitis
Pathogen Group Specific Microorganisms Frequency (%) Virulence & Clinical Characteristics
Coagulase-Negative Staphylococci (CoNS) Staphylococcus epidermidis (predominant), S. lugdunensis ~70% Biofilm producers; low-to-moderate virulence; indolent onset; best visual prognosis ( > 80 % >80\% > 80% achieve ≥ 20 / 100 \ge 20/100 ≥ 20/100 ).
Staphylococcus aureus Methicillin-sensitive (MSSA) and Methicillin-resistant (MRSA) 10–15% High virulence; potent exotoxins; aggressive inflammatory destruction; intermediate visual outcomes.
Streptococcus species Streptococcus pneumoniae , S. viridans , S. pyogenes ~10% Highly virulent; rapid enzymatic tissue destruction; dense fibrin coagulum; poor visual recovery.
Gram-Negative Bacilli Pseudomonas aeruginosa , Enterobacter , Klebsiella , Proteus 5–10% Devastating necrotising intraocular destruction; rapid corneal melting; worst visual prognosis.
The Landmark Endophthalmitis Vitrectomy Study (EVS)
EVS studied acute postoperative bacterial endophthalmitis after cataract extraction or secondary-IOL implantation in the 1990s. Immediate vitrectomy benefited eyes with light-perception-only acuity; better-vision eyes had similar outcomes with initial tap/inject and vitrectomy. This is evidence for that population and technology, not a rule that hand-motions acuity forbids modern vitrectomy.
The systemic antibiotics tested did not improve outcomes; that does not establish that every systemic antimicrobial is useless in every endophthalmitis type. Endogenous, fungal, traumatic and bleb-related infections differ and can require systemic therapy, source control or different surgery. Consider pathogen, progression, retinal visibility, lens/capsule infection, pressure and response. Do not delay effective intravitreal treatment awaiting culture or a surgery slot.
Sampling and Intravitreal Treatment
Obtain vitreous and sometimes aqueous samples for microscopy and culture, with molecular tests when indicated. Samples must reach the appropriate laboratory promptly. Coordinate with the vitreoretinal surgeon and microbiologist and document prior antibiotics. A negative culture does not exclude infection.
Common empiric adult intravitreal coverage is vancomycin 1 mg/0.1 mL and ceftazidime 2.25 mg/0.1 mL. Pharmacy preparation, final concentration, syringe labelling and route checks are essential. Give separate syringes according to validated local protocol; a bedside dilution recipe is not adequate quality assurance. Allergy and local susceptibility may require an alternative such as amikacin, whose retinal toxicity risk needs particular care. Intravitreal corticosteroid adjunct evidence is uncertain and does not justify delaying antibiotics.
Follow closely for clinical response, pressure, retinal status and the need for repeat treatment or vitrectomy. Repeated doses are a clinical decision, not dependent only on a positive culture. Inform the patient about prognosis, treatment urgency and possible additional surgery.
Bleb-Associated Endophthalmitis
Bleb-associated endophthalmitis develops as a late, vision-threatening complication following glaucoma filtration surgery (trabeculectomy or express shunt). It can arise months, years, or decades postoperatively (mean onset: 2 to 5 years).
Pathophysiological Risk Factors
Thin, avascular, transconjunctival, cystic filtration blebs resulting from intraoperative antifibrotic antimetabolites ( Mitomycin C [MMC] or 5-Fluorouracil [5-FU] );
- Inferiorly situated trabeculectomy blebs (bathed in contaminated tear film pools);
- Late bleb leaks (positive Seidel test);
Chronic blepharitis and recurrent conjunctivitis.
Clinical Staging
Blebitis : A purulent inflamed bleb without established vitreous involvement requires urgent intensive antimicrobial management and close review according to local protocol. Check for a leak and posterior extension; progression to endophthalmitis needs intravitreal treatment and surgical assessment.
Stage 2 (Bleb-Associated Endophthalmitis): Microorganisms breach the thin conjunctival wall and enter the anterior chamber and vitreous cavity. Presents with severe ocular pain, profound visual loss, dense anterior chamber fibrin, hypopyon, and marked vitritis.
Microbiology: Aggressive virulent upper respiratory tract and oral commensals: Streptococcus pneumoniae , Haemophilus influenzae , Moraxella catarrhalis , and Pseudomonas aeruginosa . Visual prognosis is significantly poorer than acute post-cataract endophthalmitis, frequently demanding urgent vitrectomy.
Post-Traumatic Endophthalmitis
Post-traumatic endophthalmitis develops in 3% to 10% of penetrating open-globe injuries, escalating to > 15 % >15\% > 15% in the presence of a retained intraocular foreign body (IOFB) .
- Key Risk Factors
- Delayed primary surgical wound closure ( > 24 hours >24\text{ hours} > 24 hours post-injury);
- Open-globe injury occurring in a rural, farmyard, or soil-contaminated environment ;
- Retained intraocular foreign body;
Traumatic rupture of the crystalline lens capsule.
Microbiology and The Bacillus cereus Emergency
Bacillus cereus : A spore-forming, Gram-positive rod responsible for up to 25% to 45% of farmyard/soil-contaminated penetrating trauma. It produces powerful necrotising exotoxins (hemolysin, cereolysin) causing fulminant panophthalmitis within 12 to 24 hours of injury . Signs include prostrating pain, high fever, systemic leukocytosis, rapid corneal chemosis and melting, a characteristic ring corneal infiltrate , and gas bubbles in the anterior chamber. Over 80% of affected eyes lose all light perception or require enucleation/evisceration within 24 to 48 hours without immediate intervention.
Other Pathogens: Coagulase-negative staphylococci, polymicrobial infections, and filamentous fungi ( Aspergillus , Fusarium ).
Therapeutic Management: Immediate primary open-globe repair and IOFB extraction, combined with intravitreal vancomycin ( 1.0 mg 1.0\text{ mg} 1.0 mg ) and ceftazidime ( 2.25 mg 2.25\text{ mg} 2.25 mg ). Unlike post-cataract endophthalmitis, systemic intravenous antibiotics ARE indicated (IV vancomycin 1 g 1\text{ g} 1 g q12h + IV ceftazidime 2 g 2\text{ g} 2 g q8h or ciprofloxacin) to prevent orbital cellulitis and extraocular extension.
Endogenous Endophthalmitis
Endogenous endophthalmitis results from the hematogenous dissemination of circulating microorganisms across the blood-retinal or blood-aqueous barrier, establishing metastatic foci within the vascular choroid or retina that subsequently erupt into the vitreous.
- Predisposing Risk Factors
- Indwelling central venous lines and total parenteral nutrition (TPN);
- Intravenous drug abuse (IVDU);
- Systemic immunosuppression, chemotherapy, haematological malignancies, and diabetes mellitus;
Remote septic foci: infective endocarditis, urinary tract infections, pyogenic liver abscesses, or recent major abdominal/pelvic surgery.
Microbiology and Clinical Entities
Fungal endogenous endophthalmitis:
Candida albicans (most common): Typically occurs in patients with indwelling vascular catheters, TPN, or IVDU. Characterized by focal, fluffy, creamy-white chorioretinal infiltrates at the posterior pole, breaking through the internal limiting membrane to form characteristic spherical vitreous colonies resembling a "string of pearls" or "cotton balls" .
Aspergillus species: High mortality; observed in organ transplant recipients and profound neutropenia. Produces aggressive, elevated macular subretinal abscesses and extensive vascular thrombosis.
Management: High-dose systemic antifungals (IV Voriconazole 400 mg 400\text{ mg} 400 mg load then 200 mg 200\text{ mg} 200 mg twice daily, or oral Fluconazole 400 – 800 mg/day 400\text{--}800\text{ mg/day} 400 – 800 mg/day ) PLUS Intravitreal Amphotericin B ( 5 – 10 μ g in 0.1 mL 5\text{--}10\,\mu\text{g in }0.1\text{ mL} 5 – 10 μ g in 0.1 mL ) or Intravitreal Voriconazole ( 100 μ g in 0.1 mL 100\,\mu\text{g in }0.1\text{ mL} 100 μ g in 0.1 mL ) , combined with early therapeutic pars plana vitrectomy for vitreal involvement.
Bacterial Endogenous Endophthalmitis (40–50% of cases):
Klebsiella pneumoniae : Highly endemic across East Asia (Taiwan, Korea, Singapore); strongly linked to cryptogenic pyogenic liver abscesses in diabetic patients carrying the hypervirulent K1/K2 capsular serotype. Causes explosive, catastrophic panophthalmitis with subretinal abscesses and high bilateral incidence (up to 25%).
Staphylococcus aureus & Streptococcus pneumoniae : Associated with infective tricuspid endocarditis (in IVDU) and pneumococcal meningitis/pneumonia.
Management: Comprehensive systemic sepsis workup (blood cultures × 3 \times 3 × 3 , echocardiography, abdominal ultrasound/CT, urine culture), high-dose intravenous systemic antimicrobial therapy directed at the primary source, accompanied by immediate intravitreal vancomycin + ceftazidime and early vitrectomy.